在喘中的不同生物标本中表达胸膜流体淋巴蛋白:系统性审查和元分析
Izabela Orzołek1,2, Patrycja Kowalczyk2,3, Aleksandra Rybka-Frączek2
1Doctoral School of Medical University of Warsaw, Warsaw, Poland.
Frontiers in allergy
|December 8, 2025
概括
在喘患者中,胸膜 stromal lymphopoietin (TSLP) 水平升高.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 生物标志物研究 生物标志物研究
背景情况:
- 胸膜 stromal 淋巴蛋白 (TSLP) 是一种与喘相关的上皮细胞因子.
- 在各种生物样本中TSLP的表达和喘中的临床相关性尚未完全理解.
研究的目的:
- 在喘患者的血液和呼吸道样本中系统地审查和元分析TSLP度.
- 澄清TSLP作为喘潜在生物标志物的作用.
主要方法:
- 在PubMed,科学网,Embase和Cochrane图书馆进行系统的文献搜索,截至2024年10月.
- 包括40项研究进行定性综合和5项研究进行元分析.
- 使用随机效应模型的标准化平均差异 (SMD) 的元分析.
主要成果:
- 与对照组相比,喘患者的血中TSLP度显著更高 (SMD = 3.66).
- 支气管活检和支气管膜洗液 (BALf) 显示,喘患者的TSLP总是更高.
- 在诱导的唾液,呼出的气凝液 (EBC) 和鼻腔样本中的TSLP水平显示出不同的结果.
结论:
- 血中TSLP升高是喘患者的一致发现.
- 呼吸道标本中的TSLP显示了多样化的表达模式.
- 增加TSLP度可能作为喘的有价值的疾病相关标志物.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K


